Tag Archives: Eugene Williams

Lessons from Biotech: Tweaking the Imperfections

An increasing number of small biotech companies are being hatched to focus on a single disease or condition. The strategy goes against the diversified portfolio approach most big pharma companies have embraced, and instead puts all the eggs in one basket. Dart Therapeutics—one such company—has taken on Duchenne Muscular Dystrophy (DMD), a disease found in […]
Posted in Biotech, Orphan Drugs, R&D, Strategy | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta